5 Oversold Biotech Stocks To Buy Right Now
In this article, we will be taking a look at 5 oversold biotech stocks to buy right now.
Ovid Therapeutics Inc. (OVID)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Rubric Capital Management David Rosen | 5,315,969 | $6,272,843 | 0.1% | |
| 2. | Madison Avenue Partners Eli Samaha | 4,116,773 | $4,857,793 | +1% | 0.45% |
| 3. | Biotechnology Value Fund / BVF Inc Mark Lampert | 3,853,818 | $4,547,505 | 0.13% | |
| 4. | Driehaus Capital Richard Driehaus | 1,400,191 | $1,652,225 | 0.01% | |
| 5. | Prosight Capital Lawrence Hawkins | 729,208 | $860,465 | -33% | 0.21% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.76 | 18,248 | Officer, Director | 3,616,715 | 2024-03-18 | Filing | |
| $5.84 | 8,488 | Large Shareholder, Officer, Director | 5,792,530 | 2020-08-28 | Filing | |
| $2.50 | 2,000,000 | Large Shareholder | 5,750,000 | 2019-10-08 | Filing | |
| $2.50 | 60,000 | Large Shareholder, Officer, Director | 4,736,529 | 2019-10-08 | Filing | |
| $2.02 | 10,000 | Director | 20,000 | 2019-02-26 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.15 | 17,344 | Officer | 0 | 2022-09-12 | Filing | |
| $3.71 | 34,017 | Officer | 726,823 | 2021-07-14 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,319,918 | $13,910,136 | 0% | |
| 2. | 2,989,777 | $9,627,083 | 0% | |
| 3. | 1,631,742 | $5,254,209 | 0% | |
| 4. | 1,232,923 | $3,970,436 | 0% | |
| 5. | 1,120,347 | $3,607,517 | 0% |
News See All
20 Countries With Highest Rate of Epilepsy
In this article, we will take a detailed look at the 20 countries with the highest rates of epilepsy with insights into number of epilepsy cases by country and population.
5 Best Biotech Stocks to Buy Under $10
Ovid Therapeutics Inc. (NASDAQ:OVID) is an emerging biotech company that designs therapies for epilepsies, seizure-related disorders, and neurological disorders.
10 Best Biotech Stocks Under $10
In this article, we will look at the 10 best biotech stocks under $10.
Timothy P. Lynch's Stonepine Capital Portfolio: Top 5 Healthcare Stocks
In this article, we discuss the top 5 healthcare stock picks of Timothy P. Lynch's Stonepine Capital. If you want our detailed analysis of these stocks, go directly to Timothy P.
5 Pharmaceutical Stocks to Buy According to Timothy Lynch's Stonepine Capital
In this article, we will discuss the 5 pharmaceutical stocks to buy according to Timothy Lynch's Stonepine Capital based on Q2 2021 holdings of the fund.
Is OVID A Good Stock To Buy Right Now?
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change their opinion towards a...
Is Ovid Therapeutics Inc. (OVID) Going to Burn These Hedge Funds?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Hedge Funds Have Never Been More Bullish On Ovid Therapeutics Inc. (OVID)
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November.
Granite Point Capital’s Returns, AUM, and Holdings
Warren Lammert founded Granite Point Capital, a long/short hedge fund with a focus on small-cap companies, in January 2004. The fund is headquartered in Boston, Massachusetts, and Mr.